Details

Nanoscience and Nanotechnology for Human Health


Nanoscience and Nanotechnology for Human Health


Applications of Nanotechnology 1. Aufl.

von: Bert Müller, Marcel Van de Voorde

151,99 €

Verlag: Wiley-VCH (D)
Format: EPUB
Veröffentl.: 28.11.2016
ISBN/EAN: 9783527692064
Sprache: englisch
Anzahl Seiten: 410

DRM-geschütztes eBook, Sie benötigen z.B. Adobe Digital Editions und eine Adobe ID zum Lesen.

Beschreibungen

<p>Unique in combining the expertise of practitioners from university hospitals and that of academic researchers, this timely monograph presents selected topics catering specifically to the needs and interests of natural scientists and engineers as well as physicians who are concerned with developing nanotechnology-based treatments to improve human health.</p> <p>To this end, the book cover the materials aspects of nanomedicine, such as the hierarchical structure of biological materials, the imaging of hard and soft tissues and, in particular, concrete examples of nanotechnology-based approaches in modern medical treatments. The whole is rounded off by a discussion of the opportunities and risks of using nanotechnology and nanomaterials in medicine, backed by case studies taken from real life.</p>
<p>Nanomedicine: Present Accomplishments and Far-Reaching Promises XXI</p> <p><b>Part One Introduction to Nanoscience in Medicine of the Twenty-First Century 1</b></p> <p><b>1 Challenges and Opportunities of Nanotechnology for Human Health 3</b><br /><i>Bert Müller</i></p> <p>References 6</p> <p><b>2 Nanoscience and Nanotechnology and the Armory for the Twenty-First Century Health Care 9</b><br /><i>Marcel Van de Voorde and Pankaj Vadgama</i></p> <p>2.1 Conceptual Dream 9</p> <p>2.2 A Real World Encounter 9</p> <p>2.3 Mapping the Microcosm of Disease 10</p> <p>2.4 Delivery at the Clinical “Coal Face” 10</p> <p>2.5 A High Precision Aim for Disease Targets 10</p> <p>2.6 A Materials Revolution for Clinical Care 11</p> <p>2.7 Robotics for Microrepair and Healing 12</p> <p>2.8 A Dialog with Cells 12</p> <p>2.9 Stealth Materials for a More Potent Delivery 13</p> <p>2.10 Improved Biointerrogation for a Better Understanding 13</p> <p>2.11 Crossing the Structure–Function Threshold 14</p> <p>2.12 Living Implants for a Living Matrix 15</p> <p>2.13 Taming the Nanointerface 15</p> <p>2.14 Where are We Now? 16</p> <p>2.15 Where will the Revolution Take Us? 16</p> <p>2.16 Conclusions 17</p> <p>References 18</p> <p><b>3 Nanomedicine Activities in the United States and Worldwide 21</b><br /><i>Carlotta Borsoi, Joy Wolfram, and Mauro Ferrari</i></p> <p>3.1 Drug Delivery 22</p> <p>3.2 Diagnostics 31</p> <p>3.3 Scaffolds 33</p> <p>3.4 Clinically Approved Nanoproducts 37</p> <p>References 39</p> <p><b>Part Two Leading Cause of Death: Cardiovascular Diseases 51</b></p> <p><b>4 Challenges in Cardiovascular Treatments Using Nanotechnology-Based Approaches 53</b><br /><i>Till Saxer and Margaret N. Holme</i></p> <p>4.1 Introduction 53</p> <p>4.2 Unmet Needs in Cardiology 54</p> <p>4.3 Nanoparticles for Treatment of CVD 58</p> <p>4.4 Nanotherapeutics in Surgical Interventions 62</p> <p>4.5 Conclusions 65</p> <p>References 66</p> <p><b>5 Smart Container for Targeted Drug Delivery 71</b><br /><i>Andreas Zumbuehl</i></p> <p>5.1 Introduction 71</p> <p>5.2 Liposomes 72</p> <p>5.3 Shear Forces and Vesicles 76</p> <p>5.4 Conclusions 79</p> <p>References 79</p> <p><b>6 Human Nano-Vesicles in Physiology and Pathology 83</b><br /><i>Arun Cumpelik and Jürg A. Schifferli</i></p> <p>6.1 Introduction 83</p> <p>6.2 Nomenclature and Definition 84</p> <p>6.3 Stimulus for Vesicle Release 85</p> <p>6.4 Overview of Extracellular Vesicle Biology 86</p> <p>6.5 NVs of Polymorphonuclear Leukocytes 88</p> <p>6.6 Erythrocyte NVs 89</p> <p>6.7 Platelet NVs 91</p> <p>6.8 Conclusions 92</p> <p>Acknowledgment 93</p> <p>References 93</p> <p><b>7 Challenges and Risks of Nanotechnology in Medicine: An Immunologist’s Point of View 97</b><br /><i>János Szebeni</i></p> <p>7.1 Introduction 97</p> <p>7.2 The Immune Stimulatory Vicious Cycle 98</p> <p>7.3 The Cause of Immune Recognition of Nanomedicines: Similarity to Viruses 100</p> <p>7.4 Processes in the Immune Stimulatory Vicious Cycle 101</p> <p>7.5 Particle Features Influencing the Immune Side Effects of Nanomedicines 109</p> <p>7.6 Experimental Analysis of the Adverse Immune Effects of Nanomedicines 110</p> <p>7.7 Decision Tree to Guide the Evaluation of the CARPAgenic Potential of Nanomedicines 113</p> <p>7.8 Outlook 114</p> <p>References 114</p> <p><b>Part Three Second Most Common Cause of Death: Cancer 125</b></p> <p><b>8 Challenges of Applying Targeted Nanostructures with Multifunctional Properties in Cancer Treatments 127</b><br /><i>Jean-Luc Coll and Jungyoon Choi</i></p> <p>8.1 Introduction 127</p> <p>8.2 Enhanced Permeability and Retention Effect 128</p> <p>8.3 Physicochemical Factors that Influence NP Passive Properties 129</p> <p>8.4 Targeted NPs 134</p> <p>8.5 Conclusions 143</p> <p>Acknowledgments 144</p> <p>References 145</p> <p><b>9 Highly Conformal Radiotherapy Using Protons 157</b><br /><i>Antony John Lomax</i></p> <p>9.1 Introduction 157</p> <p>9.2 Proton Physics 161</p> <p>9.3 Delivering Proton Therapy 165</p> <p>9.4 Clinical Applications 172</p> <p>9.5 The Future of Proton Therapy 177</p> <p>9.6 Is There a Role for Nanotechnology in Proton Therapy? 183</p> <p>References 186</p> <p><b>10 Self-Organization on a Chip: From Nanoscale Actin Assemblies to Tumor Spheroids 191</b><br /><i>Cora-Ann Schoenenberger and Thomas Pfohl</i></p> <p>10.1 Introduction 192</p> <p>10.2 Microfluidic Cell Culture 197</p> <p>10.3 Self-Regulated Loading of Cells into Microchambers 197</p> <p>10.4 2D Cell Culture in Microfluidics 200</p> <p>10.5 Expanding Microfluidic Cell Culture to the Third Dimension 200</p> <p>10.6 Microfluidic Biomimetic Models of Cancer 204</p> <p>10.7 Future Perspectives 204</p> <p>Acknowledgments 205</p> <p>References 205</p> <p><b>11 The Nanomechanical Signature of Tissues in Health and Disease 209</b><br /><i>Daphne O. Asgeirsson, Philipp Oertle, Marko Loparic, and Marija Plodinec</i></p> <p>11.1 Summary 209</p> <p>11.2 Tissue Mechanics Across Length Scales 210</p> <p>11.3 Atomic Force Microscopy (AFM) in Cell and Tissue Biology 211</p> <p>11.4 The Nanomechanical Signature of Articular Cartilage 218</p> <p>11.5 The Nanomechanical Signature of Mammary Tissues 224</p> <p>11.6 AFM – The Diagnostic and Prognostic Tool of the Future 229</p> <p>Acknowledgments 232</p> <p>Competing Financial Interests 232</p> <p>References 232</p> <p><b>Part Four Most Common Diseases: Caries, Musculoskeletal Diseases, Incontinence, Allergies 241</b></p> <p><b>12 Revealing the Nano-Architecture of Human Hard and Soft Tissues by Spatially Resolved Hard X-Ray Scattering 243</b><br /><i>Hans Deyhle and Bert Müller</i></p> <p>12.1 Introduction 243</p> <p>12.2 Spatially Resolved Hard X-Ray Scattering 244</p> <p>12.3 Nanoanatomy of Human Hard and Soft Tissues 251</p> <p>12.4 Conclusions and Outlook 259</p> <p>References 259</p> <p><b>13 Regenerative Dentistry Using Stem Cells and Nanotechnology 263</b><br /><i>Thimios A. Mitsiadis and Giovanna Orsini</i></p> <p>13.1 Introduction 263</p> <p>13.2 Repair of Dental Tissues 264</p> <p>13.3 Dental Stem Cells and Their Regenerative Potential 265</p> <p>13.4 Regenerative Dentistry 267</p> <p>13.5 Nanotechnology in Dentistry 269</p> <p>13.6 Nanoscale Surface Modifications of Dental Biomaterials 270</p> <p>13.7 Concluding Remarks 279</p> <p>Acknowledgments 280</p> <p>References 280</p> <p><b>14 Nanostructured Polymers for Medical Applications 293</b><br /><i>Prabitha Urwyler and Helmut Schift</i></p> <p>14.1 Introduction 293</p> <p>14.2 Applications of Nanostructures 295</p> <p>14.3 Processes for Generation of Nanotopographies 301</p> <p>14.4 Surface Patterning of Microcantilevers Using Mold Inlays 303</p> <p>14.5 Surface Patterning Using Plasma Etching 306</p> <p>14.6 Cell Response to Surface Patterning 308</p> <p>14.7 Conclusion 309</p> <p>References 310</p> <p><b>15 Nanotechnology in the Treatment of Incontinence 315</b><br /><i>Vanessa Leung and Christian Gingert</i></p> <p>15.1 Urinary Incontinence 316</p> <p>15.2 Fecal Incontinence 321</p> <p>References 327</p> <p><b>16 Nanomedicine in Dermatology: Nanotechnology in Prevention, Diagnosis, and Therapy 329</b><br /><i>Kathrin Scherer Hofmeier and Christian Surber</i></p> <p>16.1 Introduction 329</p> <p>16.2 Nature of Nanoparticles 330</p> <p>16.3 Absorption of Nanoparticles through Skin 333</p> <p>16.4 Nanoparticles in Prevention, Diagnosis, and Therapy 336</p> <p>16.5 Regulatory Issues 344</p> <p>16.6 Public Perception of Nanoparticles in Topicals 344</p> <p>16.7 Conclusions and Future Perspectives 345</p> <p>References 347</p> <p><b>Part Five Benefiting Patients 357</b></p> <p><b>17 Therapeutic Development and the Evolution of Precision Medicine 359</b><br /><i>Gareth D. Healey and R. Steven Conlan</i></p> <p>17.1 Origins of Nanomedicine 359</p> <p>17.2 Global Nanomedicine Market 360</p> <p>17.3 Nanomedicine Cabinet 361</p> <p>17.4 Application of Nanomedicine – A Paradigm Shift 365</p> <p>17.5 Targeted Drug Discovery and the Human Kinome 367</p> <p>17.6 Translation from Discovery to the Clinic 369</p> <p>17.7 Evolution of Kinase Inhibitors 370</p> <p>17.8 Nanoparticle Delivery 372</p> <p>17.9 Conclusions 374</p> <p>References 374</p> <p><b>18 Benefit from Nanoscience and Nanotechnology: Benefitting Patients 379</b><br /><i>Bert Müller and Marcel H. Van de Voorde</i></p> <p>Index 383</p>
Bert Muller is Professor for Materials Science in Medicine at the University of Basel and teaches physics at ETH Zurich. He received a diploma in mechanical engineering, followed by M.Sc. degrees in Physics and English from the Dresden University of Technology, and obtained a PhD in experimental physics from the University of Hannover, Germany. For his achievements he was granted with the Morton M. Traum Award of the American Vacuum Society. Afterwards, he worked as researcher at the Paderborn University, Germany, as Feodor Lynen Fellow and research associate at the EPF Lausanne and as team leader at ETH Zurich. He has become a faculty member of the Physics Department at ETH Zurich. Ten years ago he has founded the Biomaterials Science Center. Currently, this center has more than twenty researchers dealing with nanotechnology-based artificial muscles for incontinence treatment, smart nano-containers to treat cardiovascular diseases, high-resolution X-ray imaging to visualize the human body down to the molecular level, computational sciences of tissues in health and disease and other applications of physics and nanosciences in medicine and dentistry. He is Fellow of SPIE and an active member of the European Academy of Sciences and Arts.<br> <br> Marcel Van de Voorde has 40 years` experience in European Research Organisations including CERN-Geneva, European Commission, with 10 years at the Max Planck Institute in Stuttgart, Germany. For many years, he was involved in research and research strategies, policy and management, especially in European research institutions. He holds a Professorship at the University of Technology in Delft, the Netherlands, as well as multiple visiting professorships in Europe and worldwide. He holds a doctor honoris causa and various honorary Professorships.<br> He is senator of the European Academy for Sciences and Arts, in Salzburg and Fellow of the World Academy for Sciences. He is a Fellow of various scientific societies and has been decorated by the Belgian King. He has authored of multiple scientific and technical publications and co-edited multiple books in the field of nanoscience and nanotechnology.

Diese Produkte könnten Sie auch interessieren:

Nanoengineering of Biomaterials
Nanoengineering of Biomaterials
von: Sougata Jana, Subrata Jana
PDF ebook
354,99 €
Physiologie kompakt für Dummies
Physiologie kompakt für Dummies
von: Donna Rae Siegfried
EPUB ebook
11,99 €
Nanoengineering of Biomaterials
Nanoengineering of Biomaterials
von: Sougata Jana, Subrata Jana
EPUB ebook
354,99 €